The Global Lower GI Series Market is expected to grow at a CAGR of 4.6% during the forecast period 2017-2023 Lower GI series is a lower gastrointestinal series or barium enema; it is one of the medical procedure, which helps in diagnosis of diseases and abnormalities related to human large intestine and rectum.
The Worldwide Lower GI Series Market has seen a prospective growth in the developed nation such as the US, Canada, Germany, U.K, Japan and others. The developed and advanced technologies have boosted the lower GI series market. This all regions come under the matured economy where the disposable income and people are very much aware about the different test and diseases. Even though the skilled and professional doctors, large number of hospitals and clinics, and laboratories where the lower GI series tests are available has also pushed the market. But in this region the cost of diagnose is very much high which can create a hurdle in the market growth.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/771 .
According to a recent study report published by the Market Research Future, the global market of lower GI series is expected to witness a prospective growth in terms of value with a substantial CAGR surpassing its previous growth records by the end of the forecasted period (2016 – 2027).
The global lower GI Series market has seen a prospective growth in the recent days. Earlier, the diagnoses of the diseases such as Colon polyps, tumors, diverticular disease, gastroenteritis, strictures crohn’s disease or icerative colitis was very complex and difficult to diagnose. But the invention of lower GI series test has pushed the healthcare industry to the upper level. The technological advancements, growing disposable income, rising people awareness about the lower GI series test has put a potential scope for the global lower GI series market across the globe. Increase in the number on healthcare centers, hospitals, clinics and laboratories have also driven the market. The major key challenges for this particular market are that X-rays observed and managed to give the minimum amount of radiation to create the picture. Most specialists feel that the danger is low contrasted and the advantages. Children and pregnant ladies are more touchy or sensitive to the risk and dangers of ionizing radiation.
The lower GI series test are examine to identify and detect the diseases such as Colon polyps, tumors, Diverticular disease, Gastroenteritis, lacerative colitis or Strictures Crohn’s disease and others such as constipation, pain or blood in the stools. The lower GI series tests are widely used by the hospitals and clinics due to the large number of patients increasing across the globe. The Lower GI series test or barium enemas are mostly used to examine the rectum or large intestine.
Major Regional Analysis of the Global Lower GI Series Market:
On the regional basis, the market is segmented into the America, Europe, Asia Pacific, and the Middle East & Africa. The America owns a significant share in the global market as a result of huge investment in research and development in the healthcare sector and its strong economic conditions for research and development.
Europe is the second largest market followed by Asia Pacific on account of increasing technological improvements. The technological improvements will result in higher efficiency and accuracy for diagnosis. Asia Pacific is the fastest growing market due to increasing prevalence of communicable diseases in this region. India and China have started investing in research and development of healthcare sector, which will boost the market growth of this region.
Order a Copy of 105 Premium Pages Copy @ https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=771 .
The Major Key players profiled in the report are:
Cadila Pharmaceuticals, PeaceHealth,
Purdue Pharma L.P.,
Mount Sinai Beth Israel,
Ironwood Pharmaceuticals Inc.
According to the National Institute of Diabetes and Digestive and Kidney Diseases, approximately 60-70 million people are affected by either major or minor GIT diseases in America. The number is continuously increasing due to poor diet and increasing aging population. The global lower GI series market is driven majorly due to increasing prevalence of GI diseases, gastric cancer, and changing lifestyle. Additionally, developing technologies, increasing cost-effective methods, and the government’s support for research have boosted the growth of this market. However, availability of alternative therapies may hamper the growth of the market during the review period.
Major TOC for Lower GI Series Market:
1 Report Prologue
2 Market Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/771 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312